Beijing Leadman Biochemistry Co.,Ltd. (SHE:300289)
China · Delayed Price · Currency is CNY 6.81
+0.09 (1.34%)
Apr 1, 2026, 3:04 PM CST
SHE:300289 Revenue
In the year 2025, Beijing Leadman Biochemistry had annual revenue of 326.31M CNY, down -11.86%. Beijing Leadman Biochemistry had revenue of 74.06M in the quarter ending December 31, 2025, a decrease of -16.23%.
Revenue
326.31M
Revenue Growth
-11.86%
P/S Ratio
11.35
Revenue / Employee
697.24K
Employees
427
Market Cap
3.70B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 326.31M | -43.92M | -11.86% |
| Dec 31, 2024 | 370.23M | -91.33M | -19.79% |
| Dec 31, 2023 | 461.55M | -244.42M | -34.62% |
| Jan 1, 2023 | 705.98M | 141.92M | 25.16% |
| Jan 1, 2022 | 564.06M | 92.55M | 19.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Guangdong Biolight Meditech | 1.05B |
| Hangzhou AGS MedTech | 597.21M |
| Ningbo David Medical Device | 516.76M |
| Dirui Industrial | 511.11M |
| Chison Medical Technologies | 447.35M |
| Nanjing Medlander Medical Technology | 431.59M |
| Wuhan Easy Diagnosis Biomedicine | 351.25M |
| Kontour (Xi'an) Medical Technology | 351.08M |